These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12051399)

  • 1. Renal tolerability of three commonly employed non-steroidal anti-inflammatory drugs in elderly patients with osteoarthritis.
    Niccoli L; Bellino S; Cantini F
    Clin Exp Rheumatol; 2002; 20(2):201-7. PubMed ID: 12051399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis.
    Cheng TT; Lai HM; Chiu CK; Chem YC
    Clin Ther; 2004 Mar; 26(3):399-406. PubMed ID: 15110132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis.
    Bianchi Porro G; Montrone F; Lazzaroni M; Manzionna G; Caruso I
    Ital J Gastroenterol Hepatol; 1999; 31(5):378-85. PubMed ID: 10470596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical study on the anti-inflammatory activity and gastrointestinal tolerability of amtolmetin guacyl, a new NSAID, compared with diclofenac in aged patients with osteoarticular diseases].
    Tavella A; Ursini G
    Clin Ter; 1997 Nov; 148(11):543-8. PubMed ID: 9494257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amtolmetin guacyl versus piroxicam in patients with osteoarthritis.
    Montrone F; Santandrea S; Caruso I; Gerli R; Cesarotti ME; Frediani P; Bassani R
    J Int Med Res; 2000; 28(2):91-100. PubMed ID: 10898121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group.
    Cannon GW; Caldwell JR; Holt P; McLean B; Seidenberg B; Bolognese J; Ehrich E; Mukhopadhyay S; Daniels B
    Arthritis Rheum; 2000 May; 43(5):978-87. PubMed ID: 10817549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rofecoxib, a new cyclooxygenase 2 inhibitor, shows sustained efficacy, comparable with other nonsteroidal anti-inflammatory drugs: a 6-week and a 1-year trial in patients with osteoarthritis. Osteoarthritis Studies Group.
    Saag K; van der Heijde D; Fisher C; Samara A; DeTora L; Bolognese J; Sperling R; Daniels B
    Arch Fam Med; 2000; 9(10):1124-34. PubMed ID: 11115219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrointestinal medications and procedures in osteoarthritis patients treated with rofecoxib compared with nonselective NSAIDs.
    Watson DJ; Harper SE; Zhao PL; Bolognese JA; Simon TJ
    MedGenMed; 2001 Nov; 3(4):6. PubMed ID: 11965201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 6-week, multicentre, randomised, double-blind, double-dummy, active-controlled, clinical safety study of lumiracoxib and rofecoxib in osteoarthritis patients.
    Stricker K; Yu S; Krammer G
    BMC Musculoskelet Disord; 2008 Sep; 9():118. PubMed ID: 18778469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs (ibuprofen, diclofenac, and nabumetone).
    Reicin AS; Shapiro D; Sperling RS; Barr E; Yu Q
    Am J Cardiol; 2002 Jan; 89(2):204-9. PubMed ID: 11792343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability profiles of rofecoxib (Vioxx) and Arthrotec. A comparison of six weeks treatment in patients with osteoarthritis.
    Acevedo E; Castañeda O; Ugaz M; Beaulieu AD; Pons-Estel B; Caeiro F; Casas N; Garza-Elizondo M; Irazoque F; Hinojosa W; Gutierrez-Ureña S; Vandormael K; Rodgers DB; Laurenzi M
    Scand J Rheumatol; 2001; 30(1):19-24. PubMed ID: 11252687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
    Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
    Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain.
    Desjardins PJ; Black PM; Daniels S; Bird SR; Fitzgerald BJ; Petruschke RA; Tershakovec A; Chang DJ
    Curr Med Res Opin; 2004 Oct; 20(10):1523-37. PubMed ID: 15462686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo controlled comparison of the morphine sparing effect of oral rofecoxib and diclofenac for acute renal colic.
    Engeler DS; Ackermann DK; Osterwalder JJ; Keel A; Schmid HP
    J Urol; 2005 Sep; 174(3):933-6. PubMed ID: 16093996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of amtolmetin guacyl in the treatment of acute osteoarthritis].
    Biasi G; Marcolongo R
    Minerva Med; 2001 Oct; 92(5):315-24. PubMed ID: 11675575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of rofecoxib, celecoxib, and naproxen on renal function in elderly subjects receiving a normal-salt diet.
    Schwartz JI; Vandormael K; Malice MP; Kalyani RN; Lasseter KC; Holmes GB; Gertz BJ; Gottesdiener KM; Laurenzi M; Redfern KJ; Brune K
    Clin Pharmacol Ther; 2002 Jul; 72(1):50-61. PubMed ID: 12152004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: a randomized controlled trial.
    Kivitz AJ; Greenwald MW; Cohen SB; Polis AB; Najarian DK; Dixon ME; Moidel RA; Green JA; Baraf HS; Petruschke RA; Matsumoto AK; Geba GP;
    J Am Geriatr Soc; 2004 May; 52(5):666-74. PubMed ID: 15086644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritis.
    Bellamy N; Bensen WG; Beaulieu A; Siminovitch KA; Kraag GR; Lussier A; Ahmad S; Khanna VN; Davis P; Bell MJ
    J Rheumatol; 1995 May; 22(5):915-20. PubMed ID: 8587082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experience of rofecoxib in patients with osteoarthritis previously treated with traditional non-steroidal anti-inflammatory drugs in Spain: results of phase 2 of the VICOXX study.
    Arboleya LR; de la Figuera E; Soledad García M; Aragón B;
    Curr Med Res Opin; 2003; 19(4):288-97. PubMed ID: 12841921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal safety of amtolmetin guacyl in comparison with celecoxib in patients with rheumatoid arthritis.
    Jajić Z; Malaise M; Nekam K; Koó E; Dankó K; Kovacs M; Scarpignato C
    Clin Exp Rheumatol; 2005; 23(6):809-18. PubMed ID: 16396699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.